Enrico F Gherlone1, Paolo Capparé2, Simona Tecco1, Elisabetta Polizzi1, Giuseppe Pantaleo3, Giorgio Gastaldi4,5, Maria Gabriella Grusovin6. 1. Dental School, Vita-Salute University and IRCCS San Raffaele, Milan, Italy. 2. Dental School, Vita-Salute University and IRCCS San Raffaele, Milan, Italy. paolocappare@gmail.com. 3. Faculty of Psychology, UniSR Social.Lab [Research Methods], Vita-Salute San Raffaele University, Milan, Italy. 4. Dental School, Vita-Salute University, Milan, Italy. 5. Maxillofacial Surgery and Dentistry Unit, San Rocco Hospital, Ome, Brescia, Italy. 6. Dental School, Vita-Salute San Raffaele University, Milan, Italy.
Abstract
BACKGROUND: A recent study showed that implant-prosthetic rehabilitation in well-controlled HIV patients gave slightly worse results than in an healthy population, and failures were all linked to infection. PURPOSE: The aim of this study was to examine the associations between the success of implant-prosthetic treatment and systemic CD4+ level, smoking habits, and oral hygiene. MATERIALS AND METHODS: This mono-centric study included HIV patients with a stable disease and good oral hygiene requiring implant rehabilitation. Each patient received at least one dental implant. Prosthesis were delivered after 90 days in the upper jaw and 60 days in the lower jaw. Primary outcome measures were prosthetic failures, implant failures, peri-implant marginal bone level changes, and biological complications (peri-implantitis, pus, pain, paresthesia). The possible association with CD4 count, smoking habits, and oral hygiene was analyzed. RESULTS: Sixty-eight patients received 194 implants, and 66 patients (190 implants) were followed for 1 year. No significant associations were found between CD4+ count, oral hygiene-associated variables, and any of the outcome measures. If compared with nonsmoking/light smoking patients, patients who smoked >10 cigarettes/day suffered a statistically significant greater number of implant failures (p ≤ .005), presented a comparatively higher number of peri-implantitis (p < .001), as well as a higher frequency of pus (p ≤ .007), and reported pain (p ≤ .009). CONCLUSION: Within the limitation of the present study, placement of dental implants in HIV-positive patients with stable disease seems a reasonable treatment option, regardless of CD4+ cell count, provided that they are in a normal range. Oral hygiene variables were not influent in this group of patient following recall appointments, while HIV-positive heavy smokers (>10 cigarettes/day) demonstrated an increased risk of early implant failure, peri-implantitis, episodes of pus, and self-reported pain.
BACKGROUND: A recent study showed that implant-prosthetic rehabilitation in well-controlled HIVpatients gave slightly worse results than in an healthy population, and failures were all linked to infection. PURPOSE: The aim of this study was to examine the associations between the success of implant-prosthetic treatment and systemic CD4+ level, smoking habits, and oral hygiene. MATERIALS AND METHODS: This mono-centric study included HIVpatients with a stable disease and good oral hygiene requiring implant rehabilitation. Each patient received at least one dental implant. Prosthesis were delivered after 90 days in the upper jaw and 60 days in the lower jaw. Primary outcome measures were prosthetic failures, implant failures, peri-implant marginal bone level changes, and biological complications (peri-implantitis, pus, pain, paresthesia). The possible association with CD4 count, smoking habits, and oral hygiene was analyzed. RESULTS: Sixty-eight patients received 194 implants, and 66 patients (190 implants) were followed for 1 year. No significant associations were found between CD4+ count, oral hygiene-associated variables, and any of the outcome measures. If compared with nonsmoking/light smoking patients, patients who smoked >10 cigarettes/day suffered a statistically significant greater number of implant failures (p ≤ .005), presented a comparatively higher number of peri-implantitis (p < .001), as well as a higher frequency of pus (p ≤ .007), and reported pain (p ≤ .009). CONCLUSION: Within the limitation of the present study, placement of dental implants in HIV-positivepatients with stable disease seems a reasonable treatment option, regardless of CD4+ cell count, provided that they are in a normal range. Oral hygiene variables were not influent in this group of patient following recall appointments, while HIV-positive heavy smokers (>10 cigarettes/day) demonstrated an increased risk of early implant failure, peri-implantitis, episodes of pus, and self-reported pain.
Authors: Aina Torrejon-Moya; Keila Izquierdo-Gómez; Mario Pérez-Sayáns; Enric Jané-Salas; Antonio Marí Roig; José López-López Journal: J Clin Med Date: 2022-04-25 Impact factor: 4.964
Authors: Fabian Duttenhoefer; Marc Anton Fuessinger; Yasmin Beckmann; Rainer Schmelzeisen; Knut A Groetz; Martin Boeker Journal: Int J Implant Dent Date: 2019-11-28
Authors: Andrea Rampi; Marco Lanzillotta; Gaia Mancuso; Alessandro Vinciguerra; Lorenzo Dagna Journal: Int J Environ Res Public Health Date: 2020-11-05 Impact factor: 3.390
Authors: Babak Saravi; Andreas Vollmer; Maja Hartmann; Gernot Lang; Ralf-Joachim Kohal; Martin Boeker; Sebastian B M Patzelt Journal: Materials (Basel) Date: 2021-05-20 Impact factor: 3.623